5[1]Matrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genetics, 1990, 6: 121-125
6[2]Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS, 1999, 107: 38-44
7[3]Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED, ed. Cell biology of extracellular matrix. New York: Plenum Press, 1991, 255-302
8[4]Birkedal-Hansen H, Moore WGl, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med, 1993, 4: 197-250
9[5]Huhtala P, Chow LT, Tryggvason K. Structure of the human Type IV collagenase gene. J Biol Chem, 1990, 265: 11 077-082
10[6]Huhtala P, Tuuttila A, Chow T, et al. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem, 1991, 266: 16 485-490
2Wild S,Roglic G,Green A,et al.Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J].Diabetes Care,2004,27(5):1047-1053.
3Mazzone T.Reducing cardiovascular disease in patients with diabetes mellitus[J].Curr Opin Cardiol,2005,20(4):245-249.
4Goldberg RB,Kandall DM,Deeg MA.A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia[J].Diabetes Care,2005,28(7):1547-1554.
5Aronne LJ,Nelinson DS,Lillo JL.Obesity as a disease state:a new paradigm for diagno sis and treatment[J].Clin Cornerstone,2009,9(4):9-25.
6Dibello R,Baylin A,Vilali S,et al.Adiponectin and type 2 diabetes in samoan adults[J].Am Hum Biol,2009,21(3):389-391.
7Bostrom MA,Freedman BI,Langefeld CD,et al.Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy[J].Diabetes,2009,58(2):499-504.
8Momiyama Y,Kawaguchi A,Kajiwara I,et al.Progno stic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease:the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study[J].Atherosclerosis,2009,207(1):272-277.
9Sourij H,Zweiker R,Wascher TC.Effects of pioglitazone on endothelial function insulin sensitivity,and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes[J].Diabetes Care,2006,29(5):1039-1045.
